Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

By N. Wolmark, Jiping Wang, E. Mamounas, J. Bryant, B. Fisher. Journal of the National Cancer Institute. Monographs, 2001

1,335 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/f9a2d0632752b3ef34640c42487c615156bbf1d6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. A. Lluch

In Oncology

1. G. Hortobagyi

Citations in the corpus

• GENOMIC PREDICTOR OF RESPONSE AND SURVIVAL FOLLOWING TAXANE-ANTHRACYCLINE CHEMOTHERAPY FOR INVASIVE BREAST CANCER (2011, methodology): “Indeterminate 0 6 (7) 6 (2) 0 0 1 (2) 1 (1)”
• Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. (2008, methodology): “Details of treatment have been described previously.(13-15) In Protocol B-27, all patients were assigned to receive four cycles of AC every 21 days before surgery.”